Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
10,454,712
-
Share change
-
+1,207,221
-
Total reported value
-
$23,627,120
-
Put/Call ratio
-
100%
-
Price per share
-
$2.26
-
Number of holders
-
36
-
Value change
-
+$2,788,485
-
Number of buys
-
21
-
Number of sells
-
8
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q1 2014
As of 31 Mar 2014,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,454,712 shares.
The largest 10 holders included
FEDERATED INVESTORS INC /PA/, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, Opaleye Management Inc., BAKER BROS. ADVISORS LP, SOPHROSYNE CAPITAL LLC, AQR CAPITAL MANAGEMENT LLC, Ghost Tree Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp.
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.